Amanda Law
Concepts (322)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 32 | 2019 | 544 | 7.100 |
Why?
| Neuregulin-1 | 17 | 2020 | 43 | 3.870 |
Why?
| Prefrontal Cortex | 13 | 2020 | 280 | 3.050 |
Why?
| Neuregulins | 5 | 2020 | 7 | 2.720 |
Why?
| Hippocampus | 16 | 2020 | 747 | 2.070 |
Why?
| ErbB Receptors | 8 | 2020 | 571 | 1.960 |
Why?
| Nerve Tissue Proteins | 10 | 2015 | 557 | 1.810 |
Why?
| Alternative Splicing | 6 | 2020 | 197 | 1.670 |
Why?
| Brain | 15 | 2021 | 2540 | 1.600 |
Why?
| Proto-Oncogene Proteins c-akt | 5 | 2020 | 433 | 1.490 |
Why?
| TOR Serine-Threonine Kinases | 3 | 2020 | 377 | 1.270 |
Why?
| Bipolar Disorder | 4 | 2016 | 207 | 1.170 |
Why?
| Choline | 8 | 2021 | 115 | 1.170 |
Why?
| Behavior, Animal | 4 | 2020 | 486 | 1.140 |
Why?
| Protein Isoforms | 10 | 2018 | 347 | 1.130 |
Why?
| Prenatal Exposure Delayed Effects | 7 | 2021 | 511 | 1.080 |
Why?
| Gene Expression Regulation, Developmental | 7 | 2020 | 852 | 1.040 |
Why?
| Cell Adhesion Molecules, Neuronal | 3 | 2015 | 35 | 1.030 |
Why?
| Genetic Predisposition to Disease | 10 | 2019 | 2359 | 0.960 |
Why?
| Antipsychotic Agents | 6 | 2016 | 197 | 0.950 |
Why?
| Gene Expression | 9 | 2018 | 1506 | 0.920 |
Why?
| Receptor, ErbB-4 | 9 | 2020 | 19 | 0.890 |
Why?
| MicroRNAs | 2 | 2019 | 661 | 0.880 |
Why?
| Phosphatidylinositol 3-Kinases | 3 | 2020 | 358 | 0.880 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 2 | 2019 | 82 | 0.800 |
Why?
| Fetus | 8 | 2021 | 699 | 0.800 |
Why?
| Brain Chemistry | 4 | 2009 | 120 | 0.780 |
Why?
| Maternal Deprivation | 3 | 2010 | 14 | 0.770 |
Why?
| Polymorphism, Single Nucleotide | 9 | 2014 | 2127 | 0.760 |
Why?
| Aging | 4 | 2020 | 1694 | 0.760 |
Why?
| Fetal Development | 7 | 2021 | 263 | 0.740 |
Why?
| RNA, Messenger | 15 | 2020 | 2720 | 0.730 |
Why?
| Sensory Gating | 2 | 2019 | 45 | 0.720 |
Why?
| Minisatellite Repeats | 1 | 2019 | 38 | 0.710 |
Why?
| C-Reactive Protein | 3 | 2020 | 363 | 0.700 |
Why?
| Signal Transduction | 9 | 2018 | 4902 | 0.670 |
Why?
| Depressive Disorder, Major | 3 | 2016 | 309 | 0.660 |
Why?
| Genotype | 8 | 2016 | 1943 | 0.630 |
Why?
| Cloning, Molecular | 2 | 2010 | 551 | 0.630 |
Why?
| gamma-Aminobutyric Acid | 3 | 2018 | 155 | 0.620 |
Why?
| Interleukin-1beta | 1 | 2019 | 383 | 0.600 |
Why?
| Gene Expression Regulation | 5 | 2019 | 2491 | 0.600 |
Why?
| Cerebral Cortex | 3 | 2011 | 430 | 0.580 |
Why?
| Glutamic Acid | 1 | 2018 | 227 | 0.570 |
Why?
| Neurophysiology | 1 | 2016 | 17 | 0.570 |
Why?
| Memory Disorders | 1 | 2017 | 170 | 0.550 |
Why?
| Multiprotein Complexes | 1 | 2017 | 152 | 0.550 |
Why?
| Microfilament Proteins | 3 | 2008 | 135 | 0.540 |
Why?
| Mood Disorders | 2 | 2008 | 122 | 0.540 |
Why?
| Neocortex | 1 | 2015 | 25 | 0.530 |
Why?
| Microtubule-Associated Proteins | 3 | 2008 | 187 | 0.520 |
Why?
| Psychomotor Performance | 2 | 2014 | 307 | 0.500 |
Why?
| Adult | 28 | 2021 | 32385 | 0.490 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2019 | 1181 | 0.490 |
Why?
| Epidermal Growth Factor | 1 | 2014 | 173 | 0.480 |
Why?
| Neurogenesis | 1 | 2014 | 106 | 0.460 |
Why?
| Gestational Age | 4 | 2021 | 787 | 0.450 |
Why?
| Alleles | 3 | 2011 | 852 | 0.420 |
Why?
| Pregnancy Complications, Infectious | 3 | 2021 | 301 | 0.420 |
Why?
| Receptors, N-Methyl-D-Aspartate | 2 | 2003 | 192 | 0.420 |
Why?
| Promoter Regions, Genetic | 4 | 2019 | 1188 | 0.410 |
Why?
| Female | 35 | 2021 | 63629 | 0.400 |
Why?
| Humans | 49 | 2024 | 122796 | 0.380 |
Why?
| Inflammation | 3 | 2021 | 2598 | 0.380 |
Why?
| Heterozygote | 1 | 2011 | 270 | 0.380 |
Why?
| Quinazolines | 1 | 2012 | 243 | 0.380 |
Why?
| Male | 30 | 2021 | 59639 | 0.380 |
Why?
| Adenine | 1 | 2012 | 227 | 0.380 |
Why?
| Pregnancy | 13 | 2021 | 5854 | 0.370 |
Why?
| Infant Behavior | 2 | 2020 | 35 | 0.360 |
Why?
| Pyramidal Cells | 3 | 2004 | 54 | 0.350 |
Why?
| Infant, Newborn | 11 | 2021 | 5430 | 0.350 |
Why?
| Phenotype | 2 | 2014 | 3070 | 0.340 |
Why?
| Paternal Deprivation | 1 | 2008 | 2 | 0.340 |
Why?
| Peptides | 1 | 2014 | 893 | 0.340 |
Why?
| Gyrus Cinguli | 1 | 2008 | 69 | 0.330 |
Why?
| Animals | 17 | 2021 | 34133 | 0.320 |
Why?
| Middle Aged | 17 | 2019 | 28563 | 0.310 |
Why?
| Genome-Wide Association Study | 5 | 2019 | 1376 | 0.310 |
Why?
| Case-Control Studies | 7 | 2019 | 3296 | 0.310 |
Why?
| Amygdala | 1 | 2008 | 180 | 0.300 |
Why?
| Disease Models, Animal | 3 | 2016 | 3799 | 0.300 |
Why?
| Young Adult | 10 | 2019 | 11094 | 0.300 |
Why?
| Cyclophilins | 2 | 2004 | 29 | 0.300 |
Why?
| Mice | 8 | 2020 | 15888 | 0.300 |
Why?
| Memory, Short-Term | 3 | 2018 | 250 | 0.290 |
Why?
| Neuronal Plasticity | 2 | 2008 | 224 | 0.290 |
Why?
| Blotting, Western | 3 | 2016 | 1225 | 0.280 |
Why?
| Infant | 10 | 2021 | 8523 | 0.280 |
Why?
| Neurobiology | 1 | 2006 | 18 | 0.280 |
Why?
| Psychotic Disorders | 2 | 2021 | 154 | 0.270 |
Why?
| Pregnancy Complications | 2 | 2021 | 462 | 0.270 |
Why?
| Neural Cell Adhesion Molecules | 2 | 2015 | 25 | 0.260 |
Why?
| Cohort Studies | 8 | 2016 | 5294 | 0.260 |
Why?
| Adolescent | 11 | 2019 | 18948 | 0.250 |
Why?
| Pneumocephalus | 1 | 2024 | 3 | 0.240 |
Why?
| Neurites | 1 | 2004 | 43 | 0.240 |
Why?
| Protein Structure, Tertiary | 1 | 2006 | 832 | 0.240 |
Why?
| Dendrites | 1 | 2004 | 88 | 0.240 |
Why?
| Neurofilament Proteins | 1 | 2003 | 33 | 0.240 |
Why?
| Antibodies, Anti-Idiotypic | 1 | 2003 | 72 | 0.230 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 346 | 0.230 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 1003 | 0.230 |
Why?
| Memory | 2 | 2016 | 242 | 0.230 |
Why?
| Calcium-Binding Proteins | 2 | 2015 | 222 | 0.230 |
Why?
| Folic Acid | 2 | 2021 | 165 | 0.230 |
Why?
| Hydrocortisone | 2 | 2020 | 315 | 0.230 |
Why?
| Aged | 10 | 2019 | 20495 | 0.220 |
Why?
| Synapses | 3 | 2004 | 347 | 0.220 |
Why?
| Heart Rate, Fetal | 1 | 2021 | 24 | 0.210 |
Why?
| Child Development | 3 | 2021 | 449 | 0.200 |
Why?
| Child, Preschool | 9 | 2021 | 9755 | 0.200 |
Why?
| In Situ Hybridization | 4 | 2010 | 324 | 0.200 |
Why?
| Risk | 2 | 2014 | 890 | 0.190 |
Why?
| Risk Factors | 7 | 2021 | 9381 | 0.190 |
Why?
| Callithrix | 3 | 2010 | 9 | 0.190 |
Why?
| Child | 11 | 2021 | 19561 | 0.190 |
Why?
| Up-Regulation | 3 | 2019 | 891 | 0.190 |
Why?
| Mothers | 3 | 2021 | 728 | 0.190 |
Why?
| Molecular Sequence Data | 3 | 2010 | 2933 | 0.190 |
Why?
| Receptor, ErbB-3 | 1 | 2020 | 42 | 0.190 |
Why?
| Nerve Growth Factors | 1 | 2020 | 71 | 0.180 |
Why?
| 5' Untranslated Regions | 1 | 2019 | 53 | 0.180 |
Why?
| Aged, 80 and over | 4 | 2016 | 6845 | 0.180 |
Why?
| Animals, Newborn | 2 | 2014 | 825 | 0.180 |
Why?
| Hallucinogens | 1 | 2021 | 75 | 0.180 |
Why?
| HEK293 Cells | 2 | 2019 | 651 | 0.170 |
Why?
| Neurons | 3 | 2019 | 1345 | 0.170 |
Why?
| Haplotypes | 4 | 2013 | 482 | 0.170 |
Why?
| Organ Specificity | 1 | 2019 | 287 | 0.170 |
Why?
| Nutritional Status | 1 | 2021 | 306 | 0.170 |
Why?
| Analysis of Variance | 3 | 2012 | 1329 | 0.160 |
Why?
| Exons | 2 | 2010 | 310 | 0.160 |
Why?
| Adrenal Cortex Hormones | 1 | 2021 | 515 | 0.160 |
Why?
| Receptor, ErbB-2 | 1 | 2020 | 321 | 0.160 |
Why?
| Age of Onset | 1 | 2019 | 479 | 0.160 |
Why?
| Mice, Transgenic | 4 | 2018 | 2079 | 0.160 |
Why?
| RNA, Long Noncoding | 1 | 2020 | 163 | 0.160 |
Why?
| Cell Lineage | 1 | 2019 | 326 | 0.150 |
Why?
| Psychiatric Status Rating Scales | 3 | 2014 | 531 | 0.150 |
Why?
| Premature Birth | 1 | 2021 | 304 | 0.150 |
Why?
| Maternal Exposure | 1 | 2019 | 148 | 0.150 |
Why?
| Solute Carrier Family 12, Member 2 | 2 | 2014 | 7 | 0.150 |
Why?
| Autopsy | 2 | 2014 | 89 | 0.150 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2015 | 120 | 0.150 |
Why?
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2017 | 60 | 0.150 |
Why?
| Betacoronavirus | 1 | 2020 | 265 | 0.150 |
Why?
| Placenta | 2 | 2021 | 648 | 0.150 |
Why?
| Genetic Markers | 2 | 2010 | 358 | 0.150 |
Why?
| Reflex, Startle | 2 | 2014 | 67 | 0.140 |
Why?
| Conditioning, Classical | 1 | 2017 | 90 | 0.140 |
Why?
| Locomotion | 1 | 2017 | 84 | 0.140 |
Why?
| Depression | 2 | 2021 | 1190 | 0.140 |
Why?
| Oxygen | 3 | 2024 | 887 | 0.130 |
Why?
| Phosphatidylcholines | 1 | 2015 | 136 | 0.130 |
Why?
| Rats, Sprague-Dawley | 3 | 2012 | 2501 | 0.130 |
Why?
| Immunohistochemistry | 3 | 2004 | 1727 | 0.130 |
Why?
| Tissue Distribution | 2 | 2006 | 339 | 0.120 |
Why?
| Fear | 1 | 2017 | 313 | 0.120 |
Why?
| Cannabis | 1 | 2021 | 389 | 0.120 |
Why?
| Genotyping Techniques | 1 | 2014 | 77 | 0.120 |
Why?
| DiGeorge Syndrome | 1 | 2013 | 22 | 0.120 |
Why?
| Blood-Brain Barrier | 1 | 2014 | 107 | 0.120 |
Why?
| Catechol O-Methyltransferase | 1 | 2013 | 19 | 0.120 |
Why?
| Child Behavior | 1 | 2015 | 238 | 0.120 |
Why?
| Transcription, Genetic | 1 | 2019 | 1355 | 0.110 |
Why?
| Double-Blind Method | 2 | 2015 | 1711 | 0.110 |
Why?
| Polymorphism, Genetic | 1 | 2016 | 666 | 0.110 |
Why?
| Mental Disorders | 1 | 2021 | 952 | 0.110 |
Why?
| Photic Stimulation | 1 | 2014 | 215 | 0.110 |
Why?
| Pharmacogenetics | 1 | 2014 | 151 | 0.110 |
Why?
| Dietary Supplements | 3 | 2021 | 473 | 0.110 |
Why?
| Amphetamine | 1 | 2012 | 23 | 0.110 |
Why?
| Cross-Over Studies | 1 | 2014 | 469 | 0.110 |
Why?
| Cell Line, Transformed | 1 | 2012 | 140 | 0.110 |
Why?
| Rats | 3 | 2012 | 5426 | 0.100 |
Why?
| Mice, Inbred C57BL | 3 | 2018 | 5020 | 0.100 |
Why?
| Cerebellum | 2 | 2004 | 205 | 0.100 |
Why?
| Biological Clocks | 1 | 2011 | 41 | 0.100 |
Why?
| Neuropsychiatry | 1 | 2011 | 15 | 0.100 |
Why?
| Synaptophysin | 2 | 2008 | 12 | 0.100 |
Why?
| Molecular Structure | 1 | 2012 | 463 | 0.100 |
Why?
| Drug Discovery | 1 | 2011 | 128 | 0.090 |
Why?
| Receptors, Mineralocorticoid | 1 | 2010 | 12 | 0.090 |
Why?
| Epistasis, Genetic | 1 | 2010 | 73 | 0.090 |
Why?
| Genetic Association Studies | 1 | 2012 | 383 | 0.090 |
Why?
| Family | 1 | 2014 | 595 | 0.090 |
Why?
| Long-Term Potentiation | 1 | 2011 | 150 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 1 | 2014 | 1981 | 0.090 |
Why?
| Adenosine | 1 | 2011 | 212 | 0.090 |
Why?
| Social Isolation | 1 | 2010 | 64 | 0.090 |
Why?
| Family Health | 1 | 2010 | 201 | 0.090 |
Why?
| Motor Activity | 1 | 2014 | 679 | 0.090 |
Why?
| Tritium | 1 | 2008 | 71 | 0.090 |
Why?
| Schizophrenic Psychology | 1 | 2009 | 119 | 0.090 |
Why?
| Receptors, Serotonin | 1 | 2008 | 35 | 0.090 |
Why?
| Gene Frequency | 1 | 2010 | 522 | 0.090 |
Why?
| Vesicular Inhibitory Amino Acid Transport Proteins | 1 | 2008 | 3 | 0.080 |
Why?
| Vesicular Glutamate Transport Protein 1 | 1 | 2008 | 3 | 0.080 |
Why?
| GAP-43 Protein | 1 | 2008 | 5 | 0.080 |
Why?
| Receptors, Glucocorticoid | 1 | 2010 | 136 | 0.080 |
Why?
| Flow Cytometry | 1 | 2012 | 1128 | 0.080 |
Why?
| Receptor, Serotonin, 5-HT1A | 1 | 2008 | 39 | 0.080 |
Why?
| Action Potentials | 1 | 2011 | 433 | 0.080 |
Why?
| Prenatal Care | 2 | 2021 | 261 | 0.080 |
Why?
| Genetic Variation | 3 | 2011 | 952 | 0.080 |
Why?
| Vitamin D | 2 | 2021 | 363 | 0.080 |
Why?
| Phosphorylation | 1 | 2012 | 1733 | 0.080 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2008 | 115 | 0.080 |
Why?
| Gene Components | 1 | 2006 | 5 | 0.080 |
Why?
| Base Sequence | 1 | 2010 | 2186 | 0.070 |
Why?
| Piperazines | 1 | 2008 | 326 | 0.070 |
Why?
| Synaptic Transmission | 1 | 2008 | 240 | 0.070 |
Why?
| B-Lymphocytes | 1 | 2012 | 936 | 0.070 |
Why?
| Reward | 1 | 2008 | 214 | 0.070 |
Why?
| Amino Acid Sequence | 1 | 2010 | 2123 | 0.070 |
Why?
| Image Processing, Computer-Assisted | 1 | 2010 | 739 | 0.070 |
Why?
| Membrane Proteins | 2 | 2010 | 1093 | 0.070 |
Why?
| Pyridines | 1 | 2008 | 440 | 0.070 |
Why?
| Autoradiography | 1 | 2004 | 73 | 0.060 |
Why?
| Receptors, Nicotinic | 1 | 2007 | 309 | 0.060 |
Why?
| Histocytochemistry | 1 | 2004 | 84 | 0.060 |
Why?
| Chlorpromazine | 1 | 2004 | 5 | 0.060 |
Why?
| Clozapine | 1 | 2004 | 21 | 0.060 |
Why?
| Risperidone | 1 | 2004 | 27 | 0.060 |
Why?
| Haloperidol | 1 | 2004 | 37 | 0.060 |
Why?
| Amino Acid Transport System X-AG | 1 | 2003 | 4 | 0.060 |
Why?
| Receptors, Glutamate | 1 | 2003 | 20 | 0.060 |
Why?
| Nerve Fibers, Myelinated | 1 | 2004 | 48 | 0.060 |
Why?
| Oligonucleotide Probes | 1 | 2003 | 54 | 0.060 |
Why?
| Receptors, Growth Factor | 1 | 2003 | 51 | 0.060 |
Why?
| Presynaptic Terminals | 1 | 2004 | 58 | 0.060 |
Why?
| Semaphorin-3A | 1 | 2003 | 2 | 0.060 |
Why?
| Purkinje Cells | 1 | 2004 | 65 | 0.060 |
Why?
| Benzodiazepines | 1 | 2004 | 125 | 0.060 |
Why?
| Brain Stem | 1 | 2004 | 104 | 0.060 |
Why?
| Cell Count | 1 | 2003 | 319 | 0.060 |
Why?
| Postmortem Changes | 2 | 2014 | 16 | 0.060 |
Why?
| Protein Binding | 1 | 2008 | 2010 | 0.060 |
Why?
| Headache | 1 | 2024 | 134 | 0.060 |
Why?
| Fluorescent Antibody Technique | 1 | 2003 | 420 | 0.060 |
Why?
| Binding Sites | 1 | 2006 | 1247 | 0.060 |
Why?
| Absorptiometry, Photon | 1 | 2003 | 230 | 0.060 |
Why?
| Pandemics | 2 | 2021 | 1401 | 0.050 |
Why?
| Pregnancy Trimester, Third | 1 | 2021 | 73 | 0.050 |
Why?
| Wechsler Scales | 1 | 2021 | 57 | 0.050 |
Why?
| Social Problems | 1 | 2021 | 11 | 0.050 |
Why?
| Vitamin A | 1 | 2021 | 55 | 0.050 |
Why?
| Nutritional Requirements | 1 | 2021 | 83 | 0.050 |
Why?
| Feasibility Studies | 1 | 2003 | 780 | 0.050 |
Why?
| Nerve Net | 1 | 2003 | 249 | 0.050 |
Why?
| Intelligence | 1 | 2021 | 140 | 0.050 |
Why?
| Nootropic Agents | 1 | 2020 | 28 | 0.050 |
Why?
| Micronutrients | 1 | 2021 | 83 | 0.050 |
Why?
| Object Attachment | 1 | 2020 | 33 | 0.050 |
Why?
| Fatty Acids, Omega-3 | 1 | 2021 | 127 | 0.050 |
Why?
| Vitamins | 1 | 2021 | 163 | 0.050 |
Why?
| Treatment Outcome | 1 | 2014 | 9692 | 0.040 |
Why?
| Magnetic Resonance Imaging | 1 | 2010 | 3264 | 0.040 |
Why?
| Pituitary-Adrenal System | 1 | 2020 | 179 | 0.040 |
Why?
| Maternal Age | 1 | 2019 | 124 | 0.040 |
Why?
| Hypothalamo-Hypophyseal System | 1 | 2020 | 215 | 0.040 |
Why?
| Reference Values | 2 | 2010 | 789 | 0.040 |
Why?
| Developmental Disabilities | 1 | 2021 | 257 | 0.040 |
Why?
| Transcription Factors | 1 | 2006 | 1616 | 0.040 |
Why?
| Stress, Psychological | 2 | 2020 | 1021 | 0.040 |
Why?
| Urinary Tract Infections | 1 | 2019 | 143 | 0.040 |
Why?
| Antibodies, Monoclonal | 1 | 2003 | 1306 | 0.040 |
Why?
| Encephalitis | 1 | 2018 | 128 | 0.040 |
Why?
| Attention | 1 | 2020 | 443 | 0.040 |
Why?
| Respiratory Tract Infections | 1 | 2019 | 335 | 0.030 |
Why?
| Pneumonia, Viral | 1 | 2020 | 361 | 0.030 |
Why?
| Coronavirus Infections | 1 | 2020 | 349 | 0.030 |
Why?
| Logistic Models | 2 | 2010 | 1995 | 0.030 |
Why?
| DNA, Recombinant | 1 | 2014 | 42 | 0.030 |
Why?
| Chromosome Deletion | 1 | 2013 | 97 | 0.030 |
Why?
| Valine | 1 | 2013 | 79 | 0.030 |
Why?
| Methionine | 1 | 2013 | 147 | 0.030 |
Why?
| Transcriptome | 1 | 2018 | 774 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2013 | 551 | 0.030 |
Why?
| Sodium-Potassium-Chloride Symporters | 1 | 2011 | 9 | 0.030 |
Why?
| New York | 1 | 2011 | 121 | 0.030 |
Why?
| Symporters | 1 | 2011 | 53 | 0.030 |
Why?
| Genetic Carrier Screening | 1 | 2010 | 26 | 0.020 |
Why?
| Epigenomics | 1 | 2011 | 108 | 0.020 |
Why?
| Glutamate Decarboxylase | 1 | 2011 | 160 | 0.020 |
Why?
| Disks Large Homolog 4 Protein | 1 | 2010 | 18 | 0.020 |
Why?
| Nitric Oxide Synthase Type I | 1 | 2010 | 26 | 0.020 |
Why?
| Time | 1 | 2010 | 81 | 0.020 |
Why?
| Movement Disorders | 1 | 2009 | 45 | 0.020 |
Why?
| Tremor | 1 | 2009 | 46 | 0.020 |
Why?
| Cognition Disorders | 1 | 2014 | 547 | 0.020 |
Why?
| Artificial Intelligence | 1 | 2010 | 146 | 0.020 |
Why?
| Molecular Targeted Therapy | 1 | 2011 | 361 | 0.020 |
Why?
| Neural Inhibition | 1 | 2009 | 165 | 0.020 |
Why?
| Siblings | 1 | 2009 | 235 | 0.020 |
Why?
| Control Groups | 1 | 2008 | 12 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2019 | 4734 | 0.020 |
Why?
| Research | 1 | 2011 | 432 | 0.020 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 432 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 408 | 0.020 |
Why?
| Immunoblotting | 1 | 2008 | 318 | 0.020 |
Why?
| Cytoplasm | 1 | 2008 | 276 | 0.020 |
Why?
| Pedigree | 1 | 2008 | 492 | 0.020 |
Why?
| Anxiety Disorders | 1 | 2009 | 326 | 0.020 |
Why?
| In Vitro Techniques | 1 | 2007 | 1130 | 0.020 |
Why?
| Research Design | 1 | 2011 | 1002 | 0.020 |
Why?
| Down-Regulation | 1 | 2007 | 654 | 0.020 |
Why?
| Cell Nucleus | 1 | 2008 | 598 | 0.020 |
Why?
| Models, Biological | 1 | 2011 | 1756 | 0.010 |
Why?
| Glutamates | 1 | 2003 | 61 | 0.010 |
Why?
| Cells, Cultured | 1 | 2011 | 4162 | 0.010 |
Why?
| Mutation | 1 | 2014 | 3493 | 0.010 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 49 | 0.010 |
Why?
| Algorithms | 1 | 2010 | 1593 | 0.010 |
Why?
| Functional Laterality | 1 | 2003 | 215 | 0.010 |
Why?
| Serine Endopeptidases | 1 | 2003 | 104 | 0.010 |
Why?
| Extracellular Matrix Proteins | 1 | 2003 | 133 | 0.010 |
Why?
| Axons | 1 | 2003 | 185 | 0.010 |
Why?
| Smoking | 1 | 2007 | 1556 | 0.010 |
Why?
| Disease Progression | 1 | 2003 | 2546 | 0.010 |
Why?
| Biomarkers | 1 | 2003 | 3662 | 0.010 |
Why?
|
|
Law's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|